A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Lopinavir/Ritonavir

DRUG

Nevirapine

Trial Locations (10)

22203

Infectious Disease Physicians Inc, Annandale

27599

Univ North Carolina at Chapel Hill / Dept of Medicine, Chapel Hill

27710

Duke Univ Med Ctr / Infectious Disease Clinic, Durham

30308

AIDS Research Consortium of Atlanta, Atlanta

60612

Rush Presbyterian St Lukes Med Ctr / Sect Infect Dise, Chicago

80262

Univ of Colorado Health Sciences Ctr, Denver

90211

Pacific Oaks Research, Beverly Hills

94110

San Francisco Gen Hosp / UCSF AIDS Program, San Francisco

152132582

Univ of Pittsburgh, Pittsburgh

452670405

Univ of Cincinnati Med Ctr / Holmes Div Mail Loc 0405, Cincinnati

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00004580 - A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors | Biotech Hunter | Biotech Hunter